Articles dans des revues avec comité de lecture (182)
46.
Clària, J., Moreau, R., Fenaille, F., Amoros, A., Junot, C., Gronbaek, H., Coenraad, M. J., Pruvost, A., Ghettas, A., Chu-Van, E., López-Vicario, C., Oettl, K., Caraceni, P., Alessandria, C., Trebicka, J., Pavesi, M., Deulofeu, C., Albillos, A., Gustot, T., Welzel, T. M., Fernandez, J., Stauber, R., Saliba, F., Butin, N., Colsch, B., Moreno, C., Durand, F., Nevens, F., Bañares, R., Benten, D., Gines, P., Gerbes, A. L., Jalan, R., Angeli, P., Bernardi, M., Arroyo, V., & CANONIC Study Investigators of the EASL Clif Consortium, G. C. A. T. E. F. F. T. S. O. C. L. F. (. C. (2019). Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis. Hepatology, 69(4), 1686-1701. doi:10.1002/hep.3036347.
Ganne-Carrié, N., Chaffaut, C., Bourcier, V., Archambeaud, I., Perarnau, J. M., Oberti, F., Roulot, D., Moreno, C., Louvet, A., Dao, T., Moirand, R., Goria, O., Nguyen-Khac, E., Carbonell, N., Antonini, T. M., Pol, S., De Ledinghen, V., Ozenne, V., Henrion, J., Péron, J. M., Tran, A., Perlemuter, G., Amiot, X., Zarski, J.-P., Beaugrand, M., & Chevret, S. (2018). Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis. Journal of hepatology, 69(6), 1274-1283. doi:10.1016/j.jhep.2018.07.02248.
Houssel-Debry, P., Coilly, A., Fougerou-Leurent, C., Jezequel, C., Duvoux, C., De Ledinghen, V., Radenne, S., Kamar, N., Leroy, V., Martino, V. D., D'Alteroche, L., Canva, V., Conti, F., Dumortier, J., Montialoux, H., Lebray, P., Botta-Fridlund, D., Tran, A., Moreno, C., Silvain, C., Besch, C., Perre, P., Francoz, C., Abergel, A., Habersetzer, F., Debette-Gratien, M., Cagnot, C., Diallo, A., Chevaliez, S., Rossignol, E., Veislinger, A., Duclos-Vallée, J.-C., & Pageaux, G.-P. (2018). 12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation. Hepatology, 68(4), 1277-1287. doi:10.1002/hep.2991849.
Nguyen-Khac, E., Thiele, M., Voican, C., Nahon, P., Moreno, C., Boursier, J., Mueller, S., De Ledinghen, V., Starkel, P., Gyune Kim, S., Fernandez Y Viesca, M., Madsen, B., Naveau, S., Krag, A., Perlemuter, G., Ziol, M., Chatelain, D., & Diouf, M. (2018). Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis. The Lancet Gastroenterology and Hepatology, 3(9), 614-625. doi:10.1016/S2468-1253(18)30124-950.
Serste, T., Cornillie, A., Njimi, H., Pavesi, M., Arroyo, V., Putignano, A., Weichselbaum, L., Deltenre, P., Degré, D., Trepo, E., Moreno, C., & Gustot, T. (2018). The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis. Journal of hepatology, 69(2), 318-324. doi:10.1016/j.jhep.2018.02.02251.
Puoti, M., Foster, G. R., Wang, S., Mutimer, D., Gane, E., Moreno, C., Chang, T. T., Lee, S. S., Marinho, R. T., Dufour, J. F., Pol, S., Hezode, C., Gordon, S. S., Strasser, S., Thuluvath, P. J., Zhang, Z., Lovell, S., Pilot-Matias, T., & Mensa, F. F. (2018). High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis. Journal of hepatology, 69(2), 293-300. doi:10.1016/j.jhep.2018.03.00752.
Trepo, E., Goossens, N., Fujiwara, N., Song, W.-M., Colaprico, A., Marot, A., Spahr, L., Demetter, P., Sempoux, C., Im, G. Y., Saldarriaga, J., Gustot, T., Devière, J., Thung, S. S., Minsart, C., Serste, T., Bontempi, G., Abdelrahman, K., Henrion, J., Degré, D., Lucidi, V., Rubbia-Brandt, L., Nair, V. D., Moreno, C., Deltenre, P., Hoshida, Y., & Franchimont, D. (2018). Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis. Gastroenterology, 154(4), 965-975. doi:10.1053/j.gastro.2017.10.04853.
Marot, A., Dubois, M., Trepo, E., Moreno, C., & Deltenre, P. (2018). Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis. PloS one, 13(1), e0190823. doi:10.1371/journal.pone.019082354.
Francque, S., Cassiman, D., Smets, F., Komuta, M., Driessen, A., Dirinck, E., Danse, E., Op de Beeck, B., van Craenenbroeck, E., Van Nieuwenhove, Y., Hubens, G., Lanthier, N., Geerts, A., Moreno, C., Verbeke, L., Reynaert, H., van Steenkiste, C., Vonghia, L., Kwanten, W. W., Weyler, J., & Trepo, E. (2018). The Belgian association for study of the liver guidance document on the management of adult and paediatric non-alcoholic fatty liver disease. Acta Gastro-Enterologica Belgica (English ed.), 81(1), 55-81.55.
Zoulim, F., Verbinnen, T., Shukla, U., Jessner, W., Moreno, C., Lee, S. S., Buggisch, P., Horban, A., Lawitz, E., Corbett, C., Lenz, O., & Fevery, B. (2018). A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection. Virology journal, 15(1), 26. doi:10.1186/s12985-018-0936-456.
Bourgeois, S., Hillewaert, V., Van Remoortere, P., Van De Logt, J., Ouwerkerk-Mahadevan, S., Horsmans, Y., Nevens, F., Van Vlierberghe, H., Moreno, C., Beumont, M., Vijgen, L., Van Eygen, V., & Luo, D. (2017). Pharmacokinetic interactions between simeprevir and ledipasvir in treatment-naive hepatitis C virus genotype 1-infected patients without cirrhosis treated with a simeprevir-sofosbuvir-ledipasvir regimen. Antimicrobial agents and chemotherapy, 61(12), e01217. doi:10.1128/AAC.01217-1757.
Marot, A., Belaid, A., Orlent, H., Serste, T., Michielsen, P., Colle, I., Laleman, W., De Galocsy, C., Reynaert, H., D'Heygere, F., Moreno, C., Doerig, C., Henrion, J., & Deltenre, P. (2017). Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients. Clinics and Research in Hepatology and Gastroenterology, 41(6), 656-663. doi:10.1016/j.clinre.2017.05.003